摘要
AMSTAR 2是在第一版的基础上最新研发的系统评价方法学质量评价工具,具有较好的评价者间一致性和实用性。AMSTAR 2的适应范围包括基于随机对照研究或非随机干预研究或两者都有的系统评价,共含16个条目,其中7个条目为关键条目,系统评价的总体质量即对总的评价结果进行分级。本文就AMSTAR 2的基本情况、评价条目和评价标准等进行解读,以期为国内的用户提供参考。
AMSTAR 2 is currently revised and updated based on the original AMSTAR instrument, which is an appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both, and has good inter-rater agreement and usability. AMSTAR 2 is applied to systematic review of RCT or NRSI or both of them. AMSTAR 2 has 16 items in total, and seven domains can critically affect the validity of a review and its conclusions. Researchers recommend that users adopt the rating process based on identification of critical domains, or some variations based on this principle. We aim to introduce AMSTAR 2 to researchers and users from china, in view of basic information, assessment items and rating overall confidence in the results of the review.
出处
《中国循证心血管医学杂志》
2018年第1期14-18,共5页
Chinese Journal of Evidence-Based Cardiovascular Medicine
